Helex

Genomic medicines for kidney diseases with high unmet need

General Information
Company Name
Helex
Founded Year
2021
Location (Offices)
New York, United States +2
Founders / Decision Makers
Number of Employees
23
Industries
Biotechnology, Clean Energy
Funding Stage
Convertible Note
Social Media

Helex - Company Profile

Helex is taking the promise of non-viral targeted delivery and genome editing to the kidney, developing first-in-class genetic medicines for renal indications. Helex combines its proprietary kidney tropic lipid nanoparticle delivery system with the Epic-Cure(TM) 3D genome-based drug designer platform to create a robust renal franchise of precise and scalable therapeutics. Our lead asset is a mutation-agnostic, potential one-and-done therapy for Autosomal Dominant Polycystic Kidney Disease that impacts over 4 million people worldwide.

Funding Rounds & Investors of Helex (0)

View All

There is no investment information

Latest News of Helex

View All

No recent news or press coverage available for Helex.

Similar Companies to Helex

View All
The UK Kidney Association - Similar company to Helex
The UK Kidney Association Improving lives by supporting all professionals in the delivery of kidney care and research
NEPHROLOGY ASSOCIATES OF THE GULF COAST, PA - Similar company to Helex
NEPHROLOGY ASSOCIATES OF THE GULF COAST, PA Trusted expertise in kidney care and treatment, from diagnosis to advanced procedures.
The Renal Project - Similar company to Helex
The Renal Project Revolutionizing the availability and delivery of dialysis therapy across India.
Clinical Renal Associates - Similar company to Helex
Clinical Renal Associates Dedicated Kidney Specialist- Serving Southeast Pennsylvania for over 40 Years.
Santa Barbara Nutrients - Similar company to Helex
Santa Barbara Nutrients We are a team of dedicated researchers and patients bringing to market safe, science-backed products for kidney health.